Literature DB >> 16646069

Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients.

Valérie Le Morvan1, Michel Longy, Catherine Bonaïti-Pellié, Binh Bui, Nadine Houédé, Jean-Michel Coindre, Jacques Robert, Philippe Pourquier.   

Abstract

There are more than 50 subtypes of soft tissue sarcomas, among which 30% are associated with specific genetic alterations, including translocations. Several studies have reported associations between cancer risk and polymorphisms of DNA repair genes from the nucleotide excision repair (NER) pathway. NER involves more than 20 proteins whose inactivation leads to xeroderma pigmentosum (XP) or cockayne syndrome (CS), among which XPD, a helicase allowing DNA strand excision by the endonuclease XPG. DNA from 93 patients with synovial sarcomas, myxoid liposarcomas, dermatofibrosarcomas protuberans (DFSP), malignant fibrous histiocytomas and leiomyosarcomas were genotyped for both XPD Lys751Gln and XPG Asp1104His polymorphisms. Departure from Hardy-Weinberg was highly significant for the XPG polymorphism with an excess of heterozygotes in synovial sarcomas (p = 1.5 x 10(-5)), myxoid liposarcomas (p = 1.5 x 10(-4)) and to a lesser extent in DFSP (p = 0.028). In the case of XPD, a significant deviation was observed in synovial sarcomas (p = 3 x 10(-6)) and DFSP (p = 0.0014). When tumors were pooled according to their genetic alterations, the proportion of carriers of the variant XPG allele was significantly increased in sarcomas with specific translocations as compared to sarcomas with complex genetics (p < 10(-9)). No difference was found for XPD. Genotyping of the tumor samples in synovial sarcomas and myxoid liposarcomas revealed frequent loss of heterozygosity for XPG, mostly due to the loss of the frequent allele. For XPD, both alleles were lost with a similar frequency. Our results raise the potential implication of the XPG Asp1104His polymorphism in the occurrence of chromosomal translocations associated with specific subtypes of sarcomas. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646069     DOI: 10.1002/ijc.22009

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population.

Authors:  Ranbir Chander Sobti; Saranjeet Kaur; Vijay Lakshmi Sharma; Shrawan Kumar Singh; Seyed Ali Hosseini; Rupinder Kler
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

2.  Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.

Authors:  P Biason; C M Hattinger; F Innocenti; R Talamini; M Alberghini; K Scotlandi; C Zanusso; M Serra; G Toffoli
Journal:  Pharmacogenomics J       Date:  2011-08-09       Impact factor: 3.550

3.  Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.

Authors:  Xicheng Song; Erich M Sturgis; Lei Jin; Zhongqiu Wang; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-02-25       Impact factor: 7.396

4.  Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Mark E Zafereo; Erich M Sturgis; Zhensheng Liu; Li-E Wang; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2009-04-15       Impact factor: 4.944

5.  Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition.

Authors:  Josée Guirouilh-Barbat; Smitha Antony; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

6.  Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.

Authors:  Mei-Ling Zhu; Mengyun Wang; Zhi-Gang Cao; Jing He; Ting-Yan Shi; Kai-Qin Xia; Li-Xin Qiu; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

7.  Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma.

Authors:  Adriano Pasqui; Anna Boddi; Domenico Andrea Campanacci; Guido Scoccianti; Andrea Bernini; Daniela Grasso; Elisabetta Gambale; Federico Scolari; Ilaria Palchetti; Annarita Palomba; Sara Fancelli; Enrico Caliman; Lorenzo Antonuzzo; Serena Pillozzi
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

8.  Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.

Authors:  Katie M O'Brien; Irene Orlow; Cristina R Antonescu; Karla Ballman; Linda McCall; Ronald DeMatteo; Lawrence S Engel
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240

9.  Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis.

Authors:  Clara Benna; Andrea Simioni; Sandro Pasquali; Davide De Boni; Senthilkumar Rajendran; Giovanna Spiro; Chiara Colombo; Calogero Virgone; Steven G DuBois; Alessandro Gronchi; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Oncotarget       Date:  2018-04-06

10.  XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies.

Authors:  Jie Zhao; Shanshan Chen; Haixia Zhou; Ting Zhang; Yang Liu; Jing He; Jinhong Zhu; Jichen Ruan
Journal:  Aging (Albany NY)       Date:  2018-05-20       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.